Analyst firms · Mizuho · AFRM

Mizuho AFRM price target and rating history

Affirm Holdings Inc. (AFRM) · Finance

Mizuho rates Affirm Holdings Inc. (AFRM) Buy with a $100 price target, as of its latest action on Jan 25, 2022. It has published 5 rating actions on AFRM since July 2021, including 0 upgrades and 0 downgrades. Across 12 firms with a AFRM price target in the last 12 months, the median target is $93.50.

Current rating

Buy

Price target

$100

Median target, all firms

$93.50

Actions on AFRM

5

Mizuho price target on AFRM

Every Mizuho rating on AFRM

• Jan 25, 2022
  ReiterateMizuho cuts its price target to $100 from $140, keeps Buy
• Dec 14, 2021
  ReiterateMizuho cuts its price target to $140 from $180, keeps Buy
• Sep 24, 2021
  ReiterateMizuho raises its price target to $150 from $110, keeps Buy
• Aug 30, 2021
  ReiterateMizuho raises its price target to $110 from $76, keeps Buy
• Jul 19, 2021
  ReiterateMizuho cuts its price target to $76 from $90, keeps Buy

How other firms rate AFRM

Each firm's latest rating and stated target in the last 12 months.

Questions about Mizuho and AFRM

What is Mizuho's price target for AFRM?

Mizuho's latest stated price target for Affirm Holdings Inc. (AFRM) is $100, from its action on Jan 25, 2022.

What is Mizuho's rating on AFRM?

Mizuho rates AFRM Buy, a bullish rating, as of Jan 25, 2022.

When did Mizuho last change its view on AFRM?

On Jan 25, 2022, Mizuho cuts its price target to $100 from $140, keeps Buy.

How does Mizuho's AFRM target compare with other analysts?

Across 12 firms with a AFRM price target in the last 12 months, the median target is $93.50.

More AFRM rating histories

• Barclays6
• Piper Sandler3
• Morgan Stanley9
• BMO Capital Markets3
• BofA Securities5
• Wells Fargo3
• Deutsche Bank3
• BTIG4
• Stephens4
• Truist Securities3
• Susquehanna3
• Compass Point4
• Jefferies5
• RBC Capital Markets4
• Credit Suisse3
• DA Davidson4

All Mizuho ratingsAFRM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.